ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2973

Clinical Features and Pulmonary Function Test Findings Associated with Large Airway Disease in Relapsing Polychondritis

Marcela A. Ferrada1, Arlene Sirajuddin2, En lin Goh3, Kaitlin Quinn4, Katherine B. Gribbons5, John Hansen-Falschen6, Nitin Seam2, Robert Colbert7, Keith A. Sikora8, Wendy Goodspeed9, Angeline Thomas2, H. Jeffrey Kim10, Allen Clint2, Marcus Chen11, James D. Katz12 and Peter C. Grayson13, 1Critical Care, National Institutes of Health, Bethesda, MD, 2National Institutes of Health, Bethesda, MD, 3Faculty of Medicine Imperial College, London, United Kingdom, 4Systemic Autoimmunity Branch, NIAMS, Bethesda, MD, 5Systemic Autoimmunity Branch, National Institute of Arthritis and Skin and Musculoskeletal Disease, Bethesda, MD, 6Medicine, University of Pennsylvania, Philadelphia, PA, 7National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 8Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 9Office of the Clinical Director, NIAMS/NIH, Bethesda, MD, 10National Institute of Deafness and Other Communication Disorders, Bethesda, MD, 11NHLBI, National Institutes of Health, Bethesda, MD, 12National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, 13National Institute of Arthritis, Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Lung

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, October 24, 2018

Title: 6W021 ACR Abstract: Misc Rheumatic & Inflam DZ II (2970–2975)

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Clinical Features and Pulmonary Function Test Findings Associated with Large Airway Disease in Relapsing Polychondritis

 

Background/Purpose:

Relapsing polychondritis (RP) is a systemic disease that can lead to fatal end-organ damage, including subglottic stenosis (SGS) and tracheobronchomalacia (TBM). The study objective was to evaluate the clinical disease features and pulmonary function test (PFT) findings associated with SGS and TBM.

Methods:

Patients 18 years and older were selected from a prospective observational cohort of RP. All patients met McAdams or Damiani’s diagnostic criteria and underwent dynamic expiratory phase CT imaging of the thorax, direct laryngoscopy, and PFTs. SGS was defined by pathological narrowing of the subglottis visualized by direct laryngoscopy. TBM was defined as antero-posterior and/or lateral flattening of the tracheal wall during expiration on dynamic CT. Percentage of tracheal collapse during mid-expiration was measured by a single radiologist. Air trapping was defined as an area of low attenuation compared to the remainder of the lung parenchyma on expiratory CT images. Lung volumes and diffusion capacity were assessed for all patients. Differences were assessed by Fisher’s exact test or Kruskal-Wallis test. Median values are presented.

Results:

A total of 46 patients were included. 9 patients (20%) had SGS, 19 patients (41%) had TBM, and 4 patients (8%) had both (Table). Patients with SGS were predominantly female (100% vs 83, p=0.07) and younger at symptom onset (33 vs 40 years, p=0.04). There was no gender or age differences in patients with TBM compared to those without (84% vs 89% female, p=0.68; 43 vs 44 years, p=0.94). No clinical symptoms were significantly associated with SGS. Patients with TBM had significantly more wheezing (68% vs 23%, p<0.01), a prior diagnosis of asthma (79% vs 22%, p<0.01), and hearing loss (47% vs 19%, p=0.05). Patients with TBM had more respiratory symptoms such as choking sensation (84% vs 66%, p=0.37) and pleuritic chest pain (32% vs 15%, p=0.27) but these differences were not statistically significant. The median tracheal collapse in patients with TBM as compared with patients without was 71% vs 19% (p<0.001). Patients with air trapping on dynamic CT scan had significantly worse tracheal collapse (58% vs 24%, p<0.01). There were no significant associations between PFT results and SGS status. Total lung capacity was significantly higher in patients with TBM (102% vs 92%, p=0.03), but no other PFT parameters were associated with TBM.

Conclusion:

SGS and TBM are relatively common in RP, and specific clinical features and PFT findings are associated with airway damage. Female gender and younger age at symptom onset are associated with SGS. Wheezing, hearing loss, air trapping, and increased total lung capacity are associated with TBM. These findings may help identify subsets of patients with RP who are likely to have large-airway involvement.

 

 

With SGS

(n = 9)

Without SGS

(n = 36)

P-value

With TBM

(n = 19)

Without TBM

(n = 25)

P-value

Sex (Female, %)

9 (100%)

30 (83%)

0.07

16 (84%)

24 (89%)

0.68

Age at symptom onset

(Years ± SD)

33

(17-36)

40

(30-46)

0.04

43

(36-57)

44

(36-50)

0.94

Clinical Symptoms

Constitutional symptoms

1 (11%)

7 (19%)

1.00

3 (16%)

5 (19%)

1.00

Inflammatory eye disease

2 (22%)

8 (22%)

1.00

4 (21%)

6 (14%)

1.00

Audiovestibular Symptoms

Vertigo

6 (66%)

23 (62%)

1.00

12 (63%)

17 (63%)

1.00

Hearing loss

2 (22%)

12 (32%)

0.70

9 (47%)

5 (19%)

0.05

Tinnitus

5 (55%)

25 (68%)

0.69

12 (63%)

18 (67%)

1.00

ENT Symptoms

Auricular chondritis

9 (100%)

35 (94%)

1.00

18 (95%)

26 (93%)

1.00

Saddle nose

1 (11%)

5 (14%)

1.00

4 (21%)

6 (13%)

1.00

Nasal chondritis

9 (100%)

35 (94%)

1.00

17 (89%)

23 (85%)

1.00

Sinonasal symptoms

5 (56%)

27 (73%)

0.40

13 (68%)

19 (70%)

1.00

Respiratory Symptoms

Voice changes

31 (89%)

8 (84%)

1.00

17 (89%)

22 (81%)

0.68

Choking sensation

7 (78%)

27 (72%)

1.00

16 (84%)

18 (66%)

0.37

Dry cough

8 (89%)

33 (89%)

1.00

18 (95%)

23 (85%)

0.38

Shortness of breath

8 (89%)

30 (81%)

1.00

16 (84%)

22 (81%)

1.00

Pleuritic chest pain

2 (22%)

8 (22%)

1.00

6 (32%)

4 (15%)

0.27

Stridor

2 (22%)

6 (16%)

0.64

4 (21%)

4 (14%)

0.70

Wheezing

3 (33%)

17 (46%)

0.71

13 (68%)

7 (26%)

<0.01

Musculoskeletal Symptoms

Tenosynovitis

4 (44%)

21 (57%)

0.71

12 (63%)

13 (48%)

0.37

Arthralgia

8 (89%)

33 (89%)

1.00

16 (84%)

24 (89%)

0.67

Costochondritis

8 (89%)

32 (86%)

1.00

17 (89%)

23 (85%)

1.00

Subglottic stenosis (SGS); Tracheobronchomalacia (TBM); Standard deviation (SD)

 


Disclosure: M. A. Ferrada, None; A. Sirajuddin, None; E. L. Goh, None; K. Quinn, None; K. B. Gribbons, None; J. Hansen-Falschen, None; N. Seam, None; R. Colbert, None; K. A. Sikora, None; W. Goodspeed, None; A. Thomas, None; H. J. Kim, None; A. Clint, None; M. Chen, None; J. D. Katz, None; P. C. Grayson, None.

To cite this abstract in AMA style:

Ferrada MA, Sirajuddin A, Goh EL, Quinn K, Gribbons KB, Hansen-Falschen J, Seam N, Colbert R, Sikora KA, Goodspeed W, Thomas A, Kim HJ, Clint A, Chen M, Katz JD, Grayson PC. Clinical Features and Pulmonary Function Test Findings Associated with Large Airway Disease in Relapsing Polychondritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/clinical-features-and-pulmonary-function-test-findings-associated-with-large-airway-disease-in-relapsing-polychondritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-features-and-pulmonary-function-test-findings-associated-with-large-airway-disease-in-relapsing-polychondritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology